EUVIMEDEUVIMED entdecken
Open Access

Lamotrigine as a Potential Therapeutic Agent for Psychosomatic Disorders: Insights from a Drug Target–Based Mendelian Randomization Study

Jingyi Tong iD

Psychiatry and Clinical Psychopharmacology · 16.06.2025 · 36 (3) · 285-292

DOI: 10.5152/pcp.2026.261269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychiatry and Clinical Psychopharmacology, online erschienen am 16.06.2025. Verfasst von Jingyi Tong. Beteiligte Einrichtung: Department of Psychiatry, Sichuan Taikang Hospital, Chengdu, China. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Psychiatry, Sichuan Taikang Hospital, Chengdu, China.

ORCID-Profile: Jingyi Tong

Zitieren

APA

Tong, J. (2025). Lamotrigine as a Potential Therapeutic Agent for Psychosomatic Disorders: Insights from a Drug Target–Based Mendelian Randomization Study. Psychiatry and Clinical Psychopharmacology, 36(3), 285-292. https://doi.org/10.5152/pcp.2026.261269

Vancouver

Tong J. Lamotrigine as a Potential Therapeutic Agent for Psychosomatic Disorders: Insights from a Drug Target–Based Mendelian Randomization Study. Psychiatry and Clinical Psychopharmacology. 2025;36(3):285-292. doi:10.5152/pcp.2026.261269

BibTeX
@article{Tong2025,
  author = {Tong, Jingyi},
  title = {Lamotrigine as a Potential Therapeutic Agent for Psychosomatic Disorders: Insights from a Drug Target–Based Mendelian Randomization Study},
  journal = {Psychiatry and Clinical Psychopharmacology},
  year = {2025},
  volume = {36},
  number = {3},
  pages = {285--292},
  doi = {10.5152/pcp.2026.261269}
}
Kostenlos starten →